Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2010
10/13/2010CN101861316A Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
10/13/2010CN101861312A 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-HT7 receptor antagonists
10/13/2010CN101861311A 5-pyridinone substituted indazoles
10/13/2010CN101861297A Biphenyl carboxylic acids and derivatives thereof
10/13/2010CN101861164A Treatment of prion protein related diseases
10/13/2010CN101857854A Mesenchymal stem cell for expressing related gene of neurotrophin family and application thereof
10/13/2010CN101857622A Adenosine derivative, and preparation method and application thereof
10/13/2010CN101857591A Hydrochloric acid tiagabine crystal formations and preparation method thereof
10/13/2010CN101857590A Chromone ketoside compounds and purification method and application thereof
10/13/2010CN101857587A 2-aryl benzothiophene derivatives or pharmaceutically acceptable salts thereof, preparation method thereof, and phrmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient
10/13/2010CN101857561A Preparation method of N-ethyl-N2S2-memantine
10/13/2010CN101856493A Compound piracetam brain protein hydrolysate tablet and preparation method thereof
10/13/2010CN101856487A Chinese medicament for treating insomnia
10/13/2010CN101856483A Chinese medicinal composition for treating intermenstrual abnormal emotion and preparation method thereof
10/13/2010CN101856482A Pure Chinese medicinal preparation for treating mental illness and preparation method thereof
10/13/2010CN101856472A Production method of bone spur pain-eliminating capsule
10/13/2010CN101856468A Medicinal composition for treating senile dementia and preparation method thereof
10/13/2010CN101856464A Medicament for treating insomnia and preparation method thereof
10/13/2010CN101856457A Medicine with kidney tonifying, essence replenishing and yang invigorating functions and preparation method thereof
10/13/2010CN101856443A Method for preparing Chinese patent medicament arisaema cum bile
10/13/2010CN101856436A Chinese medicament for treating headache
10/13/2010CN101856433A Application of Puer tea in preparing dugs for preventing oxidative stress caused by immunosenescence or other relevant disease thereof
10/13/2010CN101856421A Medicament for treating herpes zoster and preparation method thereof
10/13/2010CN101856417A Formula of Chinese patent medicament for treating dermatitis and preparation method thereof
10/13/2010CN101856401A Externally-applied Chinese medical composition for treating insomnia
10/13/2010CN101856395A Method for preparing cistanche deserticola crude drug for decoction
10/13/2010CN101856394A Chinese medicinal herb for treating schizophrenia and preparation method thereof
10/13/2010CN101856365A Application of ginsenoside Rb3 in preparing medicines for treating depressive disorder
10/13/2010CN101856363A Application of Bortezomib in preparing drugs for curing POEMS syndrome
10/13/2010CN101856353A Medicinal composition using tolperisone optical isomer as active ingredient
10/13/2010CN101856350A Application of baicalein in preparing medicaments for preventing and treating Parkinson diseases
10/13/2010CN101856336A Mecobalamin sustained-release tablet and preparation method thereof
10/13/2010CN101856329A Rizatriptan benzoate oral spray
10/13/2010CN101856326A Method for preparing medical lycorine emulsion
10/13/2010CN101396371B Content determination method of Tibet crude-medicine processing material and new use thereof
10/13/2010CN101301440B Navel plaster with powder for quieting spirit
10/13/2010CN101245107B Antihuman transferrin acceptor human source antibody and uses thereof
10/13/2010CN101199766B Medicament for treating epileps
10/13/2010CN101194990B Chinese medicine ointment for treating ache of neck, shoulder, waist and leg
10/13/2010CN101125882B Recombination PAC1 receptor agonist RMMAX and its expression method and application
10/13/2010CN101121696B Metal salt of pyritinol and hydrate of the same
10/13/2010CN101041629B New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/13/2010CN101036760B Composition having stomachic, liver-care, and hypermnesia functions and the preparing technique
10/13/2010CN101035765B Sulfonamide derivatives
10/12/2010US7812178 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors
10/12/2010US7812176 reacting hydrazone containing compound with isocyanate compound, deprotecting, halogenating; cyclization; 5-HT2A serotonin receptor modulators
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812024 such as (4R,11aR)-4-methyl-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one, used for the treatment of obesity, diabetes, atherosclerosis, dyslipidemia, anxiety, depression, psychosis, schizophrenia, sleep, sexual, obsessive compulsive and gastrointestinal disorders
10/12/2010US7812005 Glycosaminoglycans correct emotional dysfunctions without altering the normal state of consciousness, because of their ability to prevent or reduce the alteration (fluidity)of the extracellular matrix (ECM) in the brain; depolymerized sulfates of dermatan, chondroitin, heparin, keratin; psychosis
10/12/2010US7811997 From bamboo using carbon dioxide Supercritical Fluid Extraction; a mixture comprising friedelin,lupenone and homologues; hypotensive agents; anticarcinogenic agents; antitumor agents; free radical scavengers; oxidation resistance; cardiovascular disorders; sin, hair cosmetics; oral administration
10/12/2010US7811822 Modulation of neural stem cells and neural progenitor cells
10/12/2010US7811816 Isolated CD8 +T lymphocytes specifically cytotoxic for a disease causing target cell
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811587 Botulinum toxin therapy for neuropsychiatric disorders
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811559 Administering to the patient an amount of CLN2 protein (Neuronal ceroid lipofuscinoses (NCLs)) effective to reduce or eliminate the symptoms caused by the deficiencyl in CLN2 protein; Central nervous system disorders
10/12/2010US7811557 treating a human suffering from stroke by administering directly at the site of stroke human CD 34+/-, Lin-cells from umbilical cord blood (UCB) or peripheral blood, separated from other mononuclear cells prior to use
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2477903C Substituted benzofurans useful as protein kinase b activators
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2470578C Tetrahydroquinoline analogues as muscarinic agonists
10/12/2010CA2459470C Pharmaceutical composition comprising gabapentin or an analogue thereof and an .alpha.-aminoamide and its analgesic use
10/12/2010CA2457050C Prophylactic and therapeutic use of hydroxysteroids
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2413699C Topical pharmaceutical formulations and methods of treatment
10/12/2010CA2411960C Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2329751C Substituted porphyrins
10/12/2010CA2320402C Modified ciliary neurotrophic factor, method of making and methods of use thereof
10/12/2010CA2223062C 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
10/07/2010WO2010115177A1 Dosing regimen for the treatment of alzheimer's disease with sulfonyl fluorides
10/07/2010WO2010115125A2 Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/07/2010WO2010115124A2 Compositions of cholinesterase inhibitors
10/07/2010WO2010115078A2 Method of treating cognitive impairment
10/07/2010WO2010115050A2 Embryonic stem cell specific micrornas promote induced pluripotency
10/07/2010WO2010114445A1 Plant fiber product and method for its manufacture
10/07/2010WO2010114181A1 Acrylamide compounds and the use thereof
10/07/2010WO2010114179A1 3-[1,4]oxazepane-4-pyrimidone derivatives
10/07/2010WO2010114163A1 Compositions comprising 2, 4, 6-triamino-1, 3, 5-triazine derivatives for treatment of schizophrenia
10/07/2010WO2010114162A1 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
10/07/2010WO2010114121A1 Aqueous gel base and aqueous gel plaster
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010113848A1 Isothiourea derivative or isourea derivative having bace1 inhibitory activity
10/07/2010WO2010113841A1 Orally disintegrating coated tablet
10/07/2010WO2010113840A1 Solid pharmaceutical composition containing amorphous body of solifenacin
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113800A1 Dentine calcification agent and method for producing same
10/07/2010WO2010113180A2 Antipsychotic agents and standardized antipsychotic fractions from rauwolfia tetraphylla and process of their isolation
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112874A1 Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives
10/07/2010WO2010112529A1 Low dose pipamperone in treating mood disorders
10/07/2010WO2010112486A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112485A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112484A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112475A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators
10/07/2010WO2010111934A1 Lithium derivatives of pyrroloquinoline quinone and preparation method thereof
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 1833